Please log in to view this page
Username
Password
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
